Clin2
NCT07203248Possibly a fitNot yet recruiting

Real-world treatment study for vestibular migraine

Vestibular MigraineDizzinessVertigo

Part of Brain & nervous system, Ear, nose & throat clinical trials.

This study observes how vestibular migraine is treated in real-life Chinese clinical practice. It may help researchers understand which treatments work best for people with this condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,000 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with vestibular migraine or probable vestibular migraine by a doctor.
  • You have had at least 5 episodes of moderate to severe dizziness or vertigo lasting 5 minutes to 72 hours.
  • You currently have or have had migraine headaches, with or without aura.
  • You are willing to keep an electronic diary of your symptoms at least 80% of the time.
  • You have not taken more than 2 different migraine prevention medications that failed to help.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07751497Not yet recruiting· Phase 2
Comparing rimegepant and flunarizine for preventing vestibular migraine

This trial tests a new medication called rimegepant (a CGRP inhibitor, which targets a protein involved in migraine) against flunarizine (a commonly used preventive) for vestibular migraine. It aims to see if rimegepant works as well as flunarizine in reducing vertigo and dizziness episodes. If you qualify, you may receive one of these medications for several months.

Hangzhou, Zhejiang
NCT06748664Not yet recruiting· Phase 2
Testing rimegepant for vestibular migraine

This trial tests if rimegepant can help reduce dizziness from vestibular migraine. It is for people who have tried at least one other preventive treatment without success and have frequent dizzy days.

NCT07655440Not yet recruiting· Phase 4
Comparing migraine preventive treatments for tinnitus relief

This study tests whether migraine prevention medications, including newer anti-CGRP drugs, can reduce ringing in the ears (tinnitus) in people who have migraine or related headache disorders. If you have had tinnitus for at least 6 months and have a history of migraine, you may be able to join.

NCT07532109Not yet recruiting
Testing a Tool for Vestibular Migraine in Teenagers

This study is testing a new questionnaire designed to measure how vestibular migraines (migraines that cause dizziness and balance problems) affect teenagers' daily lives. Researchers want to make sure the tool is accurate and helpful for doctors to understand what teenagers with this condition experience.

Needham, Massachusetts
NCT07368140Not yet recruiting
Mild ear stimulation for dizziness and migraine

This trial tests if a mild electrical stimulation to the inner ear can reduce dizziness and migraine symptoms. It involves six short sessions over two weeks.

Calgary, Alberta
NCT07374640Not yet recruiting· Early Phase 1
Virtual reality and biofeedback for teens with chronic dizziness

This study tests whether virtual reality and biofeedback (a technique that helps you control body functions) can reduce chronic dizziness in teens. If you are an adolescent with ongoing dizziness that hasn't improved with standard treatments, this trial might help you find new ways to feel better.

Waltham, Massachusetts

Hear when a new Vestibular Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.